<SEC-DOCUMENT>0001178913-20-001741.txt : 20200605
<SEC-HEADER>0001178913-20-001741.hdr.sgml : 20200605
<ACCEPTANCE-DATETIME>20200605161032
ACCESSION NUMBER:		0001178913-20-001741
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200605
FILED AS OF DATE:		20200605
DATE AS OF CHANGE:		20200605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Check-Cap Ltd
		CENTRAL INDEX KEY:			0001610590
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36848
		FILM NUMBER:		20946406

	BUSINESS ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
		BUSINESS PHONE:		972-4-8303400

	MAIL ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2024544.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, DC 20549</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-size: 18pt;"><font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif;">&#160;</font><font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Form&#160;6-K</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PURSUANT TO RULE&#160;13a-16 OR 15d-16 UNDER</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">For June 2020</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Commission File No.&#160;001-36848</div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">Check-Cap Ltd.</div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; line-height: 1.25;">&#160; <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Check-Cap Building</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Abba Hushi Avenue</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">P.O. Box 1271</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Isfiya, 30090</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Mount Carmel, Israel</div>
      <div style="text-align: center; line-height: 1.25;">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.)</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Form 20-F&#160;&#9746; &#160; Form 40-F&#160;&#9744;</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">The press release attached as Exhibit 99.1 to this Form 6-K is being incorporated by reference into the
        Post-Effective Amendment No. 1 to the Form S-8 Registration Statement File No. 333-203384, Form S-8 Registration Statement File No. 333-226490, and into the Form F-3 Registration Statements File Nos. 333-211065 and 333-225789.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Other Information</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">On June 5, 2020, Check-Cap Ltd. issued a press release announcing the receipt of a letter from the Nasdaq Listing Qualifications. A
        copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfc2d383301a645d79ee620b6823eb20b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 10.64%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Exhibit</div>
            </td>
            <td style="width: 2.49%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.87%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2.49%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.87%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top; background-color: #FFFFFF; border-bottom: #000000 2px solid;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Exhibit No</font><font style="font-family: 'Times New Roman',Times,serif;">.&#160;</font></div>
            </td>
            <td style="width: 2.49%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.87%; vertical-align: top; background-color: rgb(255, 255, 255); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2.49%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.87%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>
            <td style="width: 2.49%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 86.87%; vertical-align: top; background-color: rgb(255, 255, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-1.htm">Press Release, dated June 5, 2020</a></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>SIGNATURES</u></div>
      <div style="text-align: center; text-indent: 27.5pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 29.7pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report
        to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div style="text-align: justify; text-indent: 29.7pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z4b764f12d76b4ad0a531c7fcccaecd15" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="vertical-align: top; font-family: 'Times New Roman',Times,serif;" colspan="2">
              <div style="line-height: 1.25;">Check-Cap Ltd.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">/s/ Alex Ovadia</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Name: Alex Ovadia</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;Date: June 5, 2020</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Title: Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using EDGARfilings PROfile 6.5.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Exhibit 99.1</font></u></div>
    <div> <br>
    </div>
    <div>
      <div id="DSPFPageHeader">
        <div style="text-align: center; line-height: 1.25;"><img width="136" height="60" src="image0.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">ISFIYA, Israel, June 5, 2020, <u>Check-Cap Ltd.</u> (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical-stage medical diagnostics company advancing the development of C-Scan&#174;, the first and
        only preparation-free ingestible capsule for the prevention of colorectal cancer through the detection of precancerous polyps, today announced that the Company received a letter from the Nasdaq Listing Qualifications (the &#8220;Letter&#8221;), indicating that
        the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Further, on April 16, 2020, in response to the COVID-19 pandemic, and the resulting related market conditions, Nasdaq has elected to provide temporary relief from the bid price requirements by
        tolling compliance through June 30, 2020. As a result of the tolling of the bid price requirements, according to the Letter, the Company has 180 calendar days from July 1, 2020, or until December 28, 2020, to regain compliance with the minimum bid
        price requirement.&#160; The Company can regain compliance, if at any time during this 180 day period, the closing bid price of its ordinary shares is at least $1 for a minimum of ten consecutive business days, in which case the Company will be provided
        with a written confirmation of compliance and this matter will be closed.&#160; The Company may then be eligible for an additional 180 day grace period if it meets the Nasdaq Capital Market's initial listing standards with the exception of the minimum
        bid price requirement.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">If the Company cannot demonstrate compliance by the end of the grace period, the Nasdaq's staff will notify the Company that its ordinary shares are subject to delisting.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The Letter has no immediate effect on the Company's Nasdaq listing or the trading of its ordinary shares, and during the grace period, as may be extended, Check-Cap's ordinary shares will continue
        to trade on the Nasdaq Capital Market under the symbol "CHEK".</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">About Check-Cap</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC)&#160;screening and prevention&#160;through the introduction of C-Scan&#174;, the&#160;first and
        only&#160;patient-friendly preparation-free&#160;screening test to detect polyps&#160;before&#160;they may transform into cancer. The Company&#8217;s&#160;disruptive&#160;capsule-based&#160;screening technology aims to significantly increase&#160;screening adherence&#160;worldwide and help millions
        of people to&#160;stay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon.
        C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Legal Notice Regarding Forward-Looking Statements</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">This press release contains "forward-looking statements." Words such as "may," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends,"
        "plans," "believes," "estimates," and similar expressions, as well as statements in future tense, often signify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be
        accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time with respect to
        future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. For a discussion of these and other risks that
        could cause such differences and that may affect the realization of forward-looking statements, please refer to the "Forward-looking Statements" and "Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2019 and
        other filings with the Securities and Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or
        revise its forward-looking statements as a result of new information, future events or otherwise.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Investor Contacts</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Irina Koffler</div>
      <div style="line-height: 1.25;">LifeSci Advisors, LLC</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">+1-646-970-4681</div>
      </div>
      <div style="line-height: 1.25;">ikoffler@lifesciadvisors.com</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Meirav Gomeh-Bauer</div>
      <div style="line-height: 1.25;">LifeSci Advisors, LLC</div>
      <div style="line-height: 1.25;">+972(0)-54-476-4979</div>
      <div style="line-height: 1.25;"><u>Meirav@lifesciadvisors.com</u></div>
      <br>
      <div style="line-height: 1.25">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "F 74# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBD9E498@?6@!:*I3ZK:6_WY5^@(K/D\6Z=&<$3'Z!?\:I0D]D)
MR2-VBN<_X333/^>=S_WRO_Q5+_PF>F_\\[G_ +Y7_P"*I^SGV%SQ[G145SW_
M  F.F_\ /.X_[Y7_ .*I?^$PT[_GG<?]\K_\51[.?8.>/<Z"BL#_ (2[3O\
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M$,F&S(12ITE)-R=K W;8]A/B?1$E\HW)W@XZ"M"*2"ZC\RVD#K]:X2;X1QM
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M@9[6Y?4[.,F-R6< <"O)2"#@]17K0FIQNCG:LQ****LD**** "BBB@ HHHH
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M/1ILWV[4G,DQYVN.]=\]PV\_*.M1,[/U-8RKR:LM"N5",VX\# ["MG0; SW
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M!7_PH_X5QXA_Z!M]_P" K_X5]2T4?6Y=@]FCY:_X5QXA_P"@;??^ K_X4?\
M"N/$/_0-OO\ P%?_  KZEHH^MR[![-'RU_PKCQ#_ - V^_\  5_\*/\ A7'B
M'_H&WW_@*_\ A7U+11];EV#V:/EK_A7'B'_H&WW_ ("O_A37^&OB!T*G3;[_
M ,!7_P *^IZ*?UN78/9H\@^$.BZUH#/:W]G=Q0Y8@RP,@[^HKU^BBN><^>7,
MRTK&#XALIKM$$2,V/[JDUAKHMV% \F7_ +]FNZHJ+C.%_L6[_P">,O\ W[-'
M]BW?_/&7_OV:[JBG<#A?[%N_^>,O_?LT?V+=_P#/&7_OV:[JBBX'"_V+=_\
M/&7_ +]FC^Q;O_GC+_W[-=U11<#A?[%N_P#GC+_W[-*NB79./*D'U0UW-%%P
M.3@\-RL09&P/0BMBUT2VMR&*@L*U**0#514&%&!3J** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
